StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST) income statement

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3031% above fair value
$404.02−10.10 (-2.44%)

Close on Nov 18, 2026Market cap $28.14BP/E 45.3Yield 0.21%

West Pharmaceutical Services Inc income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
37.6%
Operating margin
23.0%
Net margin
18.8%
Return on equity, FY2025
16.9%

Financial strength

Current ratio
2.82
Debt to equity
0.07
Debt to assets
5.0%
Cash to current liabilities
72.0%

Valuation

P/E ratio
45.3
Price to sales
8.29
Price to book
9.48
Dividend yield
0.21%

See a number that looks wrong?